RxDoctor Payments Data

Calli Vanlangendonck, PA

Physician Assistant · Kenner, LANPI 1205408275

Payments from drug & device makers

$857in general payments, 2019–2025

Across 22 payments — averaging $38.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$227
  • AstraZeneca$148
  • Calliditas Therapeutics US Inc.$109
  • Sumitomo Pharma America, Inc.$84
  • Urogen Pharma, Inc.$59
  • Johnson & Johnson$44
  • plus $187 from 7 others

What the payments were for

  • Food & beverage$72084%
  • Education$13716%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medical Device Business Services, Inc.2$227
AstraZeneca(2 entities)3$148
Calliditas Therapeutics US Inc.1$109
Sumitomo Pharma America, Inc.4$84
Urogen Pharma, Inc.2$59
Johnson & Johnson(2 entities)2$44
Boston Scientific1$42
ABC Home Medical Supply, Inc.2$35
Progenics Pharmaceuticals, Inc.1$28
Teleflex LLC1$28
Merck1$23
Hollister Incorporated1$17
Gilead1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$857 in reported general payments places this provider in the 65th percentile of 1,246 physician assistant providers in Louisiana.

See all physician assistant providers in Louisiana

Medicare billing

Part B allowed, 2024
$14,016
Medicare patients
113
Services billed
140

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Methylprednisolone75$617
Ketorolac Tromethamine29$541
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen77$411
Methocarbamol53$410
Albuterol Sulfate HfaAlbuterol Sulfate15$370
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav20$243
Cephalexin26$208
Naproxen19$204
Mupirocin18$162
Doxycycline Hyclate20$160
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim18$135
Fluticasone Propionate11$126
Famotidine11$123
Ibuprofen22$116
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen18$95

Paid to pharmacies, not to this prescriber.

Other physician assistant in Kenner

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →